ICR researchers identify new drug target for advanced prostate cancer patients
Researchers from the Institute of Cancer Research (ICR) have found that prostate cancer patients with high levels of a specific protein have significantly poorer outcomes compared to those without. The findings published in the Journal of Clinical …